US Patent 7550572 siRNA targeting cell division cycle 20 homolog (CDC20)

Patent 7550572 was granted and assigned to Dharmacon, Inc. on June, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Dharmacon, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7550572

Date of Patent

June 23, 2009

Patent Application Number

11784755

Date Filed

April 9, 2007

Patent Primary Examiner

‌

Brian Whiteman

Patent abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CDC20.